MustGrow Biologics CEO on NexusBio acquisition; plans for 2025 [Video]

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson talked with Proactive’s Stephen Gunnion about the company’s acquisition of NexusBio Ag assets from Univar Solutions Canada Ltd. Giasson emphasized the significance of this deal, highlighting how it transitions MustGrow from a pre-revenue company to one with substantial revenues. The acquisition includes an established sales team, a marketing division, and a range of synergistic products, including biologics and bio-stimulants, sold in the Canadian agricultural market.

“This acquisition is a turning point for us,” Giasson explained, noting that the deal brings immediate access to a strong distribution network and existing market relationships. He also discussed plans to leverage these assets for cost synergies, expand sales into the US, and grow its proprietary product portfolio in collaboration with Bayer.

Giasson outlined the terms of the acquisition, which includes $1.60 million in deferred payments for inventory and equipment, with additional success fees scheduled for 2025 and 2026. The CEO expressed optimism for 2025 as MustGrow integrates the NexusBio division and advances its global partnerships.

Visit Proactive’s YouTube channel for more videos, and don’t forget to like, subscribe, and turn on notifications to stay updated on future content!

#MustGrowBiologics #NexusBioAg #AgricultureInnovation #Biologics #RegenerativeAgriculture #FarmingTechnology #SustainableFarming #CropScience #Agriculture2025 #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews